• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Credo Technology Group Holding Ltd Announces Appointment of Industry Veteran Clyde Hosein to Board of Directors

    4/2/24 5:35:00 PM ET
    $CRDO
    $WOLF
    $XRAY
    Semiconductors
    Technology
    Semiconductors
    Technology
    Get the next $CRDO alert in real time by email

    Credo Technology Group Holding Ltd ("Credo" or the "Company") (NASDAQ:CRDO), an innovator in providing secure, high-speed connectivity solutions that deliver improved power efficiency as data rates and corresponding bandwidth requirements increase throughout the data infrastructure market, today announced the appointment of Clyde Hosein to the Company's board of directors effective April 3, 2024.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240401894812/en/

    Credo Technology Group Holding Ltd Announces Appointment of Industry Veteran Clyde Hosein to Board of Directors (Photo: Business Wire)

    Credo Technology Group Holding Ltd Announces Appointment of Industry Veteran Clyde Hosein to Board of Directors (Photo: Business Wire)

    "Clyde's appointment to the Credo board underscores our commitment to strong financial stewardship and strategic growth," said Bill Brennan, President and Chief Executive Officer of Credo. "His extensive experience in navigating complex financial landscapes will be invaluable as we grow as a company and continue to advance our mission of providing secure, high-speed connectivity solutions. On behalf of the entire Company, I am honored to welcome Clyde to Credo."

    Mr. Hosein commented, "I am honored to join Credo's board of directors at this pivotal juncture in the technology industry's evolution. The emergence of Generative AI applications underscores the critical importance of high bandwidth connectivity solutions, and Credo's reputation for innovation places it squarely at the forefront of this transformative landscape. I am eager to contribute my expertise to help steer the company towards even greater success."

    About Clyde Hosein

    Mr. Hosein has more than 25 years of experience as a chief financial officer responsible for the finance and accounting functions of publicly traded companies. He has served on the board of directors of Dentsply Sirona Inc. (NASDAQ:XRAY), one of the world's largest manufacturers of professional dental products and technologies, since September 2020. He has been a member of the board of directors of Wolfspeed (NYSE:WOLF), the global leader in silicon carbide technology, since December 2005.

    Most recently he served as Chief Financial Officer of AliveCor Inc., a medical device and AI company producing ECG hardware and software for consumer mobile devices, from March 2021 to April 2023. Prior to AliveCor, Mr. Hosein served as Chief Financial Officer of Automation Anywhere, Inc., an enterprise software provider of robotic process automation, from December 2017 to March 2021. From August 2013 to May 2017, he served as Executive Vice President and Chief Financial Officer of RingCentral, Inc. His other senior level financial positions have included the following: Chief Financial Officer and Chief Operating Officer of Marvell Technology Group Ltd., Vice President and Chief Financial Officer of Integrated Device Technology, Inc., and Chief Financial Officer at Candescent Technologies. Early in his career, he spent 14 years in financial and engineering roles at IBM Corporation.

    About Credo

    Our mission is to deliver high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. Credo is an innovator in providing secure, high-speed connectivity solutions that deliver improved power efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. Our innovations ease system bandwidth bottlenecks while simultaneously improving on power, security, and reliability. Our connectivity solutions are optimized for optical and electrical Ethernet applications, including the emerging 100G (or Gigabits per second), 200G, 400G, 800G and the emerging 1.6T (or Terabits per second) port markets. Credo products are based on our proprietary Serializer/Deserializer (SerDes) and Digital Signal Processor (DSP) technologies. Our product families include Integrated Circuits (ICs) for the optical and line card markets, Active Electrical Cables (AECs) and SerDes Chiplets. Our intellectual property (IP) solutions consist primarily of SerDes IP licensing.

    For more information, please visit https://www.credosemi.com. Follow Credo on LinkedIn.

    Forward-Looking Statements

    Certain matters discussed in this press release issued by Credo may constitute forward-looking statements within the meaning of the federal securities laws, and could be impacted by a number of factors, including those described under the section entitled "Risk Factors" in Credo's most recent Annual Report on Form 10-K, as such factors may be updated from time to time in the Company's periodic filings with the Securities and Exchange Commission, which are accessible at www.sec.gov. Credo undertakes no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise, except as required by applicable law. From time to time, Credo may use its website as a distribution channel of material Company information. Credo routinely posts financial and other important information regarding the Company in the Investor Relations section of its website at https://investors.credosemi.com/ and encourages investors to consult that section regularly.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240401894812/en/

    Get the next $CRDO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CRDO
    $WOLF
    $XRAY

    CompanyDatePrice TargetRatingAnalyst
    Credo Technology Group Holding Ltd
    $CRDO
    2/19/2026$165.00Buy
    Goldman
    DENTSPLY SIRONA Inc.
    $XRAY
    2/19/2026$17.00Neutral → Buy
    BofA Securities
    Credo Technology Group Holding Ltd
    $CRDO
    1/21/2026$170.00Neutral
    Rosenblatt
    DENTSPLY SIRONA Inc.
    $XRAY
    12/9/2025$12.00Underweight
    Barclays
    Credo Technology Group Holding Ltd
    $CRDO
    12/2/2025$190.00 → $240.00Buy
    TD Cowen
    DENTSPLY SIRONA Inc.
    $XRAY
    11/7/2025Outperform → Mkt Perform
    William Blair
    Credo Technology Group Holding Ltd
    $CRDO
    10/17/2025$165.00Overweight
    Analyst
    Credo Technology Group Holding Ltd
    $CRDO
    10/1/2025$170.00Buy
    TD Cowen
    More analyst ratings

    $CRDO
    $WOLF
    $XRAY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2026

    CHARLOTTE, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will participate in the Leerink Partners Global Healthcare Conference. Management is scheduled to present on Tuesday, March 10, 2026, at 10:00 a.m. EST. Investors and other interested parties will be able to access a live audio webcast and an audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com. About Dentsply Sirona Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation

    3/3/26 4:15:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Credo Technology Group Holding Ltd Reports Third Quarter of Fiscal Year 2026 Financial Results

    Credo Technology Group Holding Ltd (Credo) (NASDAQ:CRDO), an innovator in providing connectivity at scale through fast, reliable, and energy-efficient system solutions, today reported financial results for the third quarter of fiscal year 2026, ended January 31, 2026. Third Quarter of Fiscal Year 2026 Financial Highlights Revenue of $407.0 million, grew by 51.9% quarter over quarter and 201.5% year over year GAAP gross margin of 68.5% and non-GAAP gross margin of 68.6% GAAP operating expenses of $129.2 million and non-GAAP operating expenses of $77.4 million GAAP net income of $157.1 million and non-GAAP net income of $208.8 million GAAP diluted net income per share of $0.8

    3/2/26 4:05:00 PM ET
    $CRDO
    Semiconductors
    Technology

    Credo Acquires CoMira Solutions

    Integration of High-Performance IP Technologies and Talented Team to Advance Connectivity Solutions for AI Infrastructure Credo Technology Group Holding Ltd (Credo) (NASDAQ:CRDO), an innovator in providing connectivity at scale through fast, reliable, and energy-efficient system solutions, today announced that it has acquired high-speed connectivity IP innovator CoMira Solutions. The acquisition of CoMira brings specialized link layer, error correction (ECC) and security semiconductor IP to support the development of new and advanced system-level solutions for scale-up and scale-out AI architectures. The CoMira team of designers and engineers have created IP solutions deployed in some o

    3/2/26 9:00:00 AM ET
    $CRDO
    Semiconductors
    Technology

    $CRDO
    $WOLF
    $XRAY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Forbes James D bought $67,345 worth of shares (5,000 units at $13.47) (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/3/26 4:52:23 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Director Varon Leslie F bought $99,999 worth of shares (9,337 units at $10.71), increasing direct ownership by 19% to 57,343 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    11/25/25 5:26:33 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Large owner Citigroup Inc bought $5,160,602 worth of shares (194,305 units at $26.56) and sold $5,089,994 worth of shares (194,423 units at $26.18) (SEC Form 4)

    4 - WOLFSPEED, INC. (0000895419) (Issuer)

    11/4/25 6:04:24 AM ET
    $WOLF
    Semiconductors
    Technology

    $CRDO
    $WOLF
    $XRAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief Supply Chain Office Johnson Robert Anthony was granted 9,599 shares, increasing direct ownership by 8% to 125,912 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/3/26 5:00:44 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SVP, CHRO Frohning Andrea L. was granted 8,861 shares, increasing direct ownership by 26% to 42,863 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/3/26 4:59:22 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    VP, Chief Accounting Officer Czerney Kevin was granted 1,478 shares, increasing direct ownership by 5% to 29,631 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/3/26 4:53:41 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $CRDO
    $WOLF
    $XRAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Credo Technology Group with a new price target

    Goldman initiated coverage of Credo Technology Group with a rating of Buy and set a new price target of $165.00

    2/19/26 7:51:10 AM ET
    $CRDO
    Semiconductors
    Technology

    Dentsply Sirona upgraded by BofA Securities with a new price target

    BofA Securities upgraded Dentsply Sirona from Neutral to Buy and set a new price target of $17.00

    2/19/26 7:47:02 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Rosenblatt initiated coverage on Credo Technology Group with a new price target

    Rosenblatt initiated coverage of Credo Technology Group with a rating of Neutral and set a new price target of $170.00

    1/21/26 8:55:06 AM ET
    $CRDO
    Semiconductors
    Technology

    $CRDO
    $WOLF
    $XRAY
    SEC Filings

    View All

    SEC Form 10-Q filed by Credo Technology Group Holding Ltd

    10-Q - Credo Technology Group Holding Ltd (0001807794) (Filer)

    3/3/26 5:06:28 PM ET
    $CRDO
    Semiconductors
    Technology

    Credo Technology Group Holding Ltd filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Credo Technology Group Holding Ltd (0001807794) (Filer)

    3/2/26 4:09:19 PM ET
    $CRDO
    Semiconductors
    Technology

    SEC Form 10-K filed by DENTSPLY SIRONA Inc.

    10-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)

    2/26/26 4:54:01 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $CRDO
    $WOLF
    $XRAY
    Leadership Updates

    Live Leadership Updates

    View All

    Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors

    CHARLOTTE, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointments of James (Jim) D. Forbes and Brian P. McKeon to its Board of Directors (the "Board"), effective February 27, 2026. Mr. Forbes is a veteran healthcare investment banker with 30 years of experience helping companies develop strategies to drive profitable growth and long-term value creation. Mr. Forbes is widely recognized for advising healthcare companies on complex strategic transactions and capital markets engagements. He most recently served as Vice Chairman of Investment Banking at Morgan Stanley, and he previously held senior execu

    2/24/26 4:30:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Wolfspeed Strengthens Global Sales Leadership with Addition of Semiconductor Leader, Stefan Steyerl, as VP of Sales, EMEA

    Wolfspeed, Inc. (NYSE:WOLF), a global leader in silicon carbide technology and manufacturing, today announced the appointment of Stefan Steyerl as vice president of sales, EMEA. Effective March 1, 2026, Steyerl will develop and execute Wolfspeed's regional sales strategy, driving adoption of silicon carbide solutions across automotive, industrial, and energy markets as Wolfspeed accelerates the adoption of silicon carbide technology to expand its market footprint and deliver revenue growth across the region. Steyerl brings more than 25 years of experience in the semiconductor industry, with a proven track record of building high-performance teams and achieving revenue growth across global

    2/17/26 8:00:00 AM ET
    $WOLF
    Semiconductors
    Technology

    Credo's Toucan PCIe Retimer Achieves PCI‑SIG® Compliance

    Credo Technology Group Holding Ltd (Credo) (NASDAQ:CRDO), an innovator in providing connectivity at scale through fast, reliable, and energy-efficient system solutions, announced that its PCIe® 6.0 technology-capable Toucan PCIe retimer has earned PCI-SIG® compliance at 32.0 GT/s. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210132002/en/Credo's PCIe® 6.0 technology-capable Toucan PCIe retimer has earned PCI-SIG® compliance at 32.0 GT/s. This validation enables customers to deploy Toucan confidently in PCIe 6.0 technology and previous generation systems, avoiding compatibility and debugging challenges common with legacy-onl

    2/10/26 9:00:00 AM ET
    $CRDO
    Semiconductors
    Technology

    $CRDO
    $WOLF
    $XRAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Wolfspeed Inc.

    SC 13G/A - WOLFSPEED, INC. (0000895419) (Subject)

    12/6/24 11:56:48 AM ET
    $WOLF
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.

    SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    12/6/24 10:11:29 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Wolfspeed Inc.

    SC 13G/A - WOLFSPEED, INC. (0000895419) (Subject)

    12/5/24 2:20:23 PM ET
    $WOLF
    Semiconductors
    Technology

    $CRDO
    $WOLF
    $XRAY
    Financials

    Live finance-specific insights

    View All

    Credo Technology Group Holding Ltd Reports Third Quarter of Fiscal Year 2026 Financial Results

    Credo Technology Group Holding Ltd (Credo) (NASDAQ:CRDO), an innovator in providing connectivity at scale through fast, reliable, and energy-efficient system solutions, today reported financial results for the third quarter of fiscal year 2026, ended January 31, 2026. Third Quarter of Fiscal Year 2026 Financial Highlights Revenue of $407.0 million, grew by 51.9% quarter over quarter and 201.5% year over year GAAP gross margin of 68.5% and non-GAAP gross margin of 68.6% GAAP operating expenses of $129.2 million and non-GAAP operating expenses of $77.4 million GAAP net income of $157.1 million and non-GAAP net income of $208.8 million GAAP diluted net income per share of $0.8

    3/2/26 4:05:00 PM ET
    $CRDO
    Semiconductors
    Technology

    Credo Acquires CoMira Solutions

    Integration of High-Performance IP Technologies and Talented Team to Advance Connectivity Solutions for AI Infrastructure Credo Technology Group Holding Ltd (Credo) (NASDAQ:CRDO), an innovator in providing connectivity at scale through fast, reliable, and energy-efficient system solutions, today announced that it has acquired high-speed connectivity IP innovator CoMira Solutions. The acquisition of CoMira brings specialized link layer, error correction (ECC) and security semiconductor IP to support the development of new and advanced system-level solutions for scale-up and scale-out AI architectures. The CoMira team of designers and engineers have created IP solutions deployed in some o

    3/2/26 9:00:00 AM ET
    $CRDO
    Semiconductors
    Technology

    Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook

    News Summary Q4 2025 net sales of $961 million increased 6.2%, constant currency sales increased 2.5%Q4 2025 reported net loss of ($146) million and diluted loss per share of ($0.74) driven by goodwill and intangible impairments of ($144) million, net of taxQ4 2025 adjusted EPS of $0.27FY 2026 outlook: net sales in the range of $3.5B to $3.6B; adjusted EPS of $1.40 to $1.50(1)Announced a restructuring initiative to redirect approximately $120 million annually into the Return-to-Growth Action Plan, prioritizing investments in accelerated innovation, clinical education, and sales team education focused on connected dentistryInitiated new capital allocation strategy by eliminating the dividend

    2/26/26 4:01:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care